Acumen Hypotension Prediction Index EV1000 Clinical Platform

by Edwards Lifesciences  · Based in United States → — The leading global structural heart innovation company, driven by a passion to improve patient lives.
Anesthesiology Critical Care Emergency Medicine

Regulatory Status Disclosed

Overview

The Acumen Hypotension Prediction Index (HPI) software is a pioneering technology developed by Edwards Lifesciences, designed to detect and help clinicians manage hemodynamic instability and predict the likelihood of hypotensive events. It operates on the HemoSphere Advanced Monitoring Platform, and previously on the EV1000 Clinical Platform. The software utilizes a machine-learning based algorithm that analyzes over 2.6 million features from a single arterial pressure waveform, comparing them against 133 million different waveforms to identify factors that predict hypotension up to 15 minutes before an event.

Key elements of the Acumen HPI software include the HPI Parameter, which displays a value from 0 to 100 indicating the likelihood of a hypotensive event; Smart Alerts and a Smart Trend screen that notify clinicians of potential trends toward hypotension; and a Relationship View screen. This Relationship View provides insights into the root cause of hypotension by visually arranging hemodynamic parameters related to preload, afterload, and contractility.

The Acumen HPI software aims to reduce the incidence and duration of intraoperative hypotension (IOH), which is strongly associated with risks of myocardial injury, acute kidney injury, and mortality. Studies have shown that using Acumen HPI software can significantly reduce the duration of IOH, with one study demonstrating a 57% reduction.

The software can be unlocked by either the minimally-invasive Acumen IQ sensor, which connects to an existing radial arterial line, or the noninvasive Acumen IQ cuff, providing continuous blood pressure and advanced hemodynamic parameters.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • HPI Parameter (0-100 likelihood score)
  • Smart Alerts for trending hypotension
  • Smart Trend screen
  • Relationship View screen (preload, afterload, contractility insights)
  • Machine learning-based algorithm for prediction
  • Predicts hypotension up to 15 minutes in advance
  • Continuous hemodynamic monitoring
  • Non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options
  • Reduces duration of intraoperative hypotension
  • Acumen Analytics software for retrospective data analysis

Use Cases

  • Prevention of intraoperative hypotension (IOH)
  • Management of hemodynamic instability in surgical patients
  • Guidance for goal-directed hemodynamic therapy (GDHT)
  • Monitoring in non-cardiac surgery
  • Monitoring in cardiac surgery
  • Patient monitoring in intensive care settings

What Physicians Need to Know

Hypotension Prediction
The Acumen Hypotension Prediction Index (HPI) software uses machine learning to predict the likelihood of a hypotensive event (mean arterial pressure < 65 mmHg for at least one minute) before it occurs. It analyzes arterial waveform information and provides a numerical index from 0 to 100, with higher values indicating a greater likelihood of hypotension. The HPI has demonstrated superior predictive ability over commonly measured perioperative hemodynamic variables.
Real-Time Alert Capability
When the HPI exceeds 85 for two consecutive 20-second updates, or reaches 100 at any time, a pop-up alert appears on the monitor to notify clinicians. This provides a warning of impending hypotension, allowing for proactive intervention.
Cardiac Monitoring Integration
The Acumen HPI software runs on the Edwards Lifesciences EV1000 Clinical Platform and is used with the Acumen IQ sensor (or FloTrac IQ sensor) and an arterial catheter for continuous blood pressure monitoring. It also integrates with the HemoSphere platform.
Hemodynamic Parameter Analysis
The system provides a secondary screen with quantitative hemodynamic parameters, including cardiac output, stroke volume variation, change of pressure over time (dP/dt), systemic vascular resistance, and dynamic arterial elastance (Eadyn), to help clinicians assess the root cause of impending hypotension.
Impact on Hypotension Duration
Clinical studies have shown that the use of Acumen HPI software, especially when combined with a personalized treatment protocol, can significantly reduce the incidence and duration of intraoperative hypotension in non-cardiac surgical patients.
Physician Tip

The Acumen HPI software is a decision support tool that provides early warning of impending hypotensive events, allowing for proactive management. It is crucial to use the HPI in conjunction with a comprehensive review of the patient's hemodynamics and not as the sole basis for therapeutic decisions. The secondary screen offering advanced hemodynamic parameters can help identify the underlying cause of hypotension, guiding appropriate interventions. Studies suggest that integrating HPI with a protocolized treatment can lead to a reduction in the incidence and duration of hypotension.

The Acumen HPI software is designed to operate on the Edwards Lifesciences EV1000 Clinical Platform and is compatible with the Acumen IQ sensor (or FloTrac IQ sensor) and an arterial catheter for continuous blood pressure monitoring. It is also integrated with the HemoSphere advanced monitoring platform.

Details

Category Cardiology AI, Surgical AI, Triage & ER/ICU AI
Pricing Unknown
DeploymentOn-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform)
Data Export Yes
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated

The Acumen Hypotension Prediction Index (HPI) software received FDA 510(k) clearance in 2021 for use with the noninvasive Acumen IQ finger cuff. It had previously received De Novo clearance in 2018 for use with invasive arterial lines. The Acumen HPI feature is intended for use in surgical patients receiving advanced hemodynamic monitoring to provide physiological insight into a patient's likelihood of future hypotensive events.

SOC 2 Yes AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Anesthesiology, Critical Care, Emergency Medicine

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2019-05-21K183646 510(k)Acumen Hypotension Prediction Index – EV1000 Clinical Platform

What the Web Says

The Acumen Hypotension Prediction Index (HPI) on the EV1000 Clinical Platform is an AI-enabled cardiovascular diagnostic tool designed to predict hypotensive events. It is associated with cardiovascular workflows and is utilized by cardiologists and clinical teams in hospital and acute care settings. The system aims to provide real-time insights to help clinicians manage patient hemodynamics.

Overall: Positive

Strengths

  • AI-enabled cardiovascular diagnostics product
  • Associated with cardiovascular workflows
  • Utilized in hospital and inpatient settings
  • Used in emergency and acute care
  • Supports cardiologists and clinical teams
  • Predicts hypotensive events

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Based on reviews from: scribd.com, physicianaitools.com, realintelligencereview.com

Last updated: 2026-10-28

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Acumen Hypotension Prediction Index EV1000 Clinical Platform

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Videos

Product demos, reviews, and walkthroughs for Acumen Hypotension Prediction Index EV1000 Clinical Platform.

Loading videos...

View all on YouTube

Frequently Asked Questions

The Acumen HPI software uses machine learning to analyze arterial waveform features and predict the likelihood of a hypotensive event (defined as Mean Arterial Pressure < 65 mmHg for at least one minute) up to 15 minutes in advance. It provides a numerical index from 0 to 100, with higher values indicating a greater probability of hypotension. The system is intended for use in surgical and non-surgical patients receiving advanced hemodynamic monitoring via the Acumen IQ sensor or the noninvasive Acumen IQ cuff.
The Acumen HPI software can help clinicians proactively manage hemodynamic instability by providing early alerts for impending hypotension, potentially reducing the incidence, duration, and severity of hypotensive events. It also offers a secondary screen with additional hemodynamic parameters to help identify the root cause of hypotension. However, the HPI feature is considered additional quantitative information and should not be used as the sole basis for therapeutic decisions. Limitations include potential inaccuracies from improper sensor placement, excessive blood pressure variations, and certain cardiac conditions like severe aortic stenosis.
The Acumen HPI algorithm was developed using over 200,000 hypotensive and non-hypotensive events and has shown a positive predictive value of at least 98% in clinical studies of surgical patients. It has received FDA clearance as an adjunctive predictive cardiovascular indicator. Studies suggest that using Acumen HPI in combination with a therapeutic protocol can reduce the incidence and duration of hypotension in non-cardiac surgical patients.
While traditional hemodynamic parameters are used to monitor blood pressure, studies suggest that Acumen HPI software is a superior predictor of hypotensive events compared to commonly used hemodynamic variables. The Acumen HPI's machine learning algorithm analyzes 23 arterial blood pressure waveform features, providing an earlier indication of hemodynamic instability and a longer reaction time for intervention.
Information regarding the specific pricing or cost implications for the Acumen Hypotension Prediction Index – EV1000 Clinical Platform is not readily available in the provided search results. One source indicates that there is currently no evidence to suggest that this technology is cost-saving.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Edwards Lifesciences

Acumen Assisted Fluid Management (AFM) Software Feature
Edwards Lifesciences
Pharmacology & Dosing AI
Acumen Assisted Fluid Management (AFM) software by Edwards Lifesciences is an AI-enhanced tool that uses machine learning to predict fluid responsiveness and provide individualized fluid recommendations for surgical patients, displayed on the HemoSphere monitor.
Acumen Hypotension Prediction Index (HPI) Feature Software
Edwards Lifesciences
Cardiology AI
Edwards Lifesciences' Acumen Hypotension Prediction Index (HPI) software is a predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes.
Global Hypoperfusion Index (GHI) Algorithm
Edwards Lifesciences
Clinical Decision Support & Reference

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-04 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.